Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00425360 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1110

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: sargramostim
BIOLOGICAL: telomerase peptide vaccine GV1001
DRUG: capecitabine
DRUG: gemcitabine hydrochloride

Sponsor

Royal Liverpool University Hospital